Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.69%
median of 501 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Actuate Therapeutics Inc
Market Cap
$20.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$21.90M
Gross Margin
63.95%
TTM Avg
66.50%
3Y Avg
67.57%
5Y Avg
61.13%
Market Cap
$18.82M
Gross Margin
10.27%
TTM Avg
10.01%
3Y Avg
10.00%
5Y Avg
11.56%
Market Cap
$18.77M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$16.58M
Gross Margin
21.95%
TTM Avg
11.59%
3Y Avg
17.76%
5Y Avg
20.87%
Market Cap
$16.54M
Gross Margin
-88.25%
TTM Avg
-11.22%
3Y Avg
9.24%
5Y Avg
11.19%
Market Cap
$25.48M
Gross Margin
0.00%
TTM Avg
49.92%
3Y Avg
18.04%
5Y Avg
44.48%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $20.93M | 0.00% | 0.00% | 0.00% | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 63.95% | 66.50% | 67.57% | 61.13% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 10.27% | 10.01% | 10.00% | 11.56% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | 91.37% | 69.42% | 78.99% | 53.34% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 21.95% | 11.59% | 17.76% | 20.87% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -88.25% | -11.22% | 9.24% | 11.19% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.00% | 49.92% | 18.04% | 44.48% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 0.00% | -3731.89% | -2384.22% | -1567.12% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
